Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Melasma

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 28, 2024

Primary Completion Date

April 28, 2025

Study Completion Date

August 1, 2026

Conditions
Melasma
Interventions
PROCEDURE

Placebo Comparator:1565 non-ablative fractional laser combined with normal Saline

Based on the patient's age, skin color, location of skin lesions, and Fitzpatrick skin type, adjust treatment parameters accordingly. The operator holds the treatment head, vertically applies parallel sweeps closely to the lesion area until the endpoint of slight skin redness is reached. After completion, apply normal Saline.

PROCEDURE

1565 non-ablative fractional laser combined with umbilical cord mesenchymal stem cell-derived exosomes.

Based on the patient's age, skin color, location of skin lesions, and Fitzpatrick skin type, adjust treatment parameters accordingly. The operator holds the treatment head, vertically applies parallel sweeps closely to the lesion area until the endpoint of slight skin redness is reached. After completion, apply exosomes.

Trial Locations (2)

350001

RECRUITING

Affiliated Union Hospital of Fujian Medical University, Fuzhou

RECRUITING

Chenxiaosong, Fujian

All Listed Sponsors
lead

Fujian Medical University Union Hospital

OTHER